Updated: September 10, 2026
Quick Answer
Investors searching for pre-IPO companies to invest in in 2026 are looking at a very different private-market landscape from even a year ago.
SpaceX, previously one of the most prominent names in private-market watchlists, completed its IPO in June 2026 and is therefore no longer a pre-IPO company.
Four private companies that still warrant research are:
- Stripe — mature fintech infrastructure with recurring employee tender liquidity;
- Databricks — fast-growing enterprise AI and data infrastructure;
- Anduril — defense technology with strong growth but unusually restrictive private-share access;
- Neuralink — frontier neurotechnology with high clinical and commercialization uncertainty.
This is not a ranking of stocks to buy.
For private companies, the company story is only one part of the decision. Investors also need to understand:
Access → Legal Structure → Entry Valuation → Fees → Transfer Restrictions → Exit Path
The broader Pre-IPO Investing Guide 2026 explains those mechanics before the company-level comparison begins.
> Disclaimer: This article is for educational and informational purposes only. The companies below are research examples, not investment recommendations, and mentioning a company does not mean its shares are currently available through MSX or another platform.
What You'll Learn
This comparison focuses on five questions:
- Is the company still privately held?
- What is the latest credible valuation signal?
- How mature is the underlying business?
- How realistic is secondary-market access?
- What could prevent an investor from exiting?
That framework matters because a well-known private company can still be a poor fit if investors cannot verify the instrument, price, rights or transfer rules.
Why This 2026 List Changed
Older pre-IPO lists frequently placed SpaceX at the top.
That is no longer accurate.
SpaceX began public trading in June 2026 under the ticker SPCX, so it should now be evaluated as a listed company rather than as a pre-IPO opportunity.
This highlights a basic rule for private-market research:
> Pre-IPO status is temporary.
A useful watchlist must therefore be updated when a company:
- completes an IPO;
- enters a formal listing process;
- raises a new private round;
- runs a tender offer;
- or experiences a major change in secondary-market access.
The four names below remain private as of this update.
Pre-IPO Companies Compared
| Company | Main Research Theme | Latest Major Valuation Signal | Private-Market Liquidity | Key Risk | |---|---|---|---|---| | Stripe | Payments & financial infrastructure | $159B tender valuation | Relatively stronger | Large valuation and unclear IPO timing | | Databricks | Enterprise data & AI | $190B funding valuation | Moderate | High AI valuation expectations | | Anduril | Defense technology | ~$61B confirmed financing reference | Restricted | Transfer restrictions and access quality | | Neuralink | Brain-computer interfaces | Primary and secondary marks vary widely | Thinner / speculative | Clinical, regulatory and commercialization risk |
These figures should not be read like public-market prices.
A private-company financing valuation, tender price and secondary-market indication can all represent different transactions with different rights.
1. Stripe: Mature Private-Market Scale
Stripe remains one of the most mature large private technology companies.
In February 2026, Stripe announced a tender offer for current and former employees at a $159 billion valuation.
The company also reported that businesses using Stripe processed approximately $1.9 trillion in payment volume during 2025, up 34% year over year.
Those figures make Stripe different from an early-stage venture company.
Its investment thesis is increasingly about:
- global payments infrastructure;
- billing and financial automation;
- stablecoins;
- AI and agentic commerce;
- long-term operating leverage.
Why Investors Watch Stripe
Stripe has a large operating business, recognizable institutional investors and recurring tender programs that can create reference points for private-market pricing.
Tender liquidity is useful because it gives investors more information than a company with almost no transactions.
But:
> A company-sponsored tender is not the same as continuous public liquidity.
An outside investor cannot assume that the tender price is continuously available.
Main Risks
The main questions include:
- whether a secondary buyer can actually access eligible shares;
- what share class is being offered;
- whether transfer approval is required;
- whether an SPV adds fees or carried interest;
- how long Stripe intends to remain private.
At a large private valuation, entry price matters considerably.
Strong business quality does not automatically mean every secondary-market price is attractive.
2. Databricks: Enterprise AI at Private-Market Scale
Databricks has become one of the largest private enterprise AI companies.
In August 2026, the company raised approximately $5 billion at a $190 billion valuation.
Reported annualized revenue reached roughly $7 billion, while the company remained cash-flow positive over the preceding year.
Its business sits at the intersection of:
- enterprise data;
- analytics;
- AI application development;
- databases;
- data governance;
- model deployment infrastructure.
Why Investors Watch Databricks
Unlike many AI startups, Databricks combines AI exposure with an established enterprise software business.
That makes the investment question less about whether AI will create demand and more about:
> How much future growth is already reflected in the private valuation?
Main Risks
A $190 billion private valuation creates a demanding starting point.
Investors should consider:
- competition from cloud platforms;
- competition from Snowflake and other data vendors;
- continued infrastructure spending;
- valuation multiples;
- future dilution;
- IPO timing.
A future listing does not guarantee that public investors will assign the same valuation multiple as private investors.
3. Anduril: Defense Technology With Restricted Access
Anduril is one of the most closely followed private defense technology companies in 2026.
Its products span areas such as:
- autonomous systems;
- drones;
- defense software;
- sensors;
- missile and rocket systems;
- manufacturing infrastructure.
A recent completed financing placed the company around a $61 billion valuation.
Subsequent reports have discussed possible financing at substantially higher levels, but proposed valuations should not be treated as completed transaction prices.
The Access Question Matters More for Anduril
Anduril itself has warned investors about third-party funds claiming access to its private shares.
The company states that its stock is privately owned and available only to a limited group of investors, and it specifically warns that certain indirect structures may attempt to work around transfer restrictions or rights of first refusal.
That makes Anduril a useful example of an important principle:
> Recognizing a company name does not prove that the investment product actually owns valid shares.
Before considering an Anduril-linked opportunity, identify whether the investor would receive:
- direct shares;
- an SPV interest;
- a fund interest;
- a forward contract;
- or another contractual exposure.
The distinction between Pre-IPO SPVs and direct share ownership becomes especially important when issuer transfer restrictions are strong.
Main Risks
Anduril's risks include:
- high valuation expectations;
- government procurement dependence;
- defense-budget and program concentration;
- regulatory and geopolitical exposure;
- restricted share transfers;
- questionable third-party access claims.
For a company-specific access example, the Anduril Pre-IPO guide focuses on instrument structure, valuation and transfer mechanics rather than simply the company narrative.
4. Neuralink: High-Uncertainty Frontier Technology
Neuralink is very different from Stripe or Databricks.
It is developing implantable brain-computer interfaces and is still primarily defined by:
- clinical development;
- technical milestones;
- regulatory progress;
- patient outcomes;
- future commercialization potential.
Neuralink's official Series E financing in 2025 raised $650 million.
Private-market estimates have moved significantly since then, but 2026 secondary-market indications vary widely.
That makes a single headline “Neuralink valuation” potentially misleading.
Why Investors Watch Neuralink
The long-term market opportunity could extend into:
- assistive computer control;
- communication for people with severe neurological impairment;
- robotic-device control;
- future visual applications.
Neuralink currently has active clinical programs investigating several of these use cases.
Why It Is Harder to Value
Stripe can be analyzed through payments volume and operating scale.
Databricks can be analyzed through enterprise revenue.
Neuralink requires much more dependence on future assumptions.
Its value can change substantially based on:
- clinical results;
- safety;
- regulatory approval;
- manufacturing scalability;
- patient adoption;
- reimbursement;
- time to commercialization.
Main Risks
Neuralink therefore carries a different risk profile:
- clinical failure;
- regulatory delays;
- medical-device liability;
- long development timelines;
- limited public financial disclosure;
- thin private-market liquidity;
- large gaps between funding-round and secondary-market valuations.
A high secondary-market bid should not be treated as equivalent to a broadly executable public-market price.
Which Pre-IPO Company Is "Best"?
There is no useful universal ranking.
The four companies represent different investment profiles.
| If You Are Researching... | Company Most Relevant to Study | |---|---| | Mature fintech infrastructure | Stripe | | Enterprise AI and data | Databricks | | Defense autonomy and manufacturing | Anduril | | Frontier neurotechnology | Neuralink |
That is a research classification, not an investment recommendation.
A more useful decision process is:
``text Company Thesis ↓ Available Instrument ↓ Legal Ownership ↓ Effective Entry Valuation ↓ Fees ↓ Liquidity ↓ Exit Terms ``
If the investment cannot pass the structural checks, the quality of the company narrative is secondary.
How to Evaluate a Pre-IPO Share Price
One of the most common mistakes is treating a private-company price like a public stock quote.
A pre-IPO share price may come from:
- the latest funding round;
- an employee tender;
- a secondary transaction;
- an SPV allocation;
- a broker indication;
- a fund valuation mark.
These are not automatically comparable.
Suppose a company's latest financing implies:
``text Company valuation: $100 billion ``
but an SPV is offering exposure at an effective:
``text $120 billion valuation ``
after markup and fees.
The investor is not entering at the headline $100 billion valuation.
The relevant figure is the effective valuation after structural costs.
Always compare:
``text Underlying Share Price + SPV / Platform Premium + Management Fee + Carry + Other Transaction Costs ``
Liquidity Matters More Than a Watchlist Ranking
Private-company shares can be difficult to sell.
Possible exit paths include:
- IPO;
- acquisition;
- issuer-approved secondary transaction;
- tender offer;
- SPV liquidation.
None is guaranteed.
A company can become more valuable while an investor remains unable to sell.
This is one of the biggest differences between pre-IPO companies and public stocks.
Before investing, check:
- ROFR provisions;
- issuer consent;
- lockups;
- transfer restrictions;
- SPV control rights;
- secondary-market availability.
Liquidity should be evaluated before potential upside.
How Investors Actually Access Private Company Stock
Private company stock is not normally purchased through the same workflow as a listed stock.
Possible routes include:
Direct Secondary Shares
An investor acquires existing shares from a shareholder, subject to company approval and transfer restrictions.
SPVs
An investment vehicle acquires or seeks to acquire shares, while the investor owns an interest in the vehicle.
Private Funds
A fund may hold stakes in several private companies.
Platform-Based Offerings
Platforms may facilitate structured subscriptions or other investment arrangements.
The instrument must be verified before funding.
A platform displaying the name “Anduril” or “Neuralink” does not by itself prove direct ownership of company stock.
The Pre-IPO account and order workflow shows where eligibility, deal documents, funding and settlement fit into this process.
Pre-IPO Company Research Checklist
Before investing in any private company, confirm:
- [ ] Is the company still private?
- [ ] What legal instrument am I buying?
- [ ] Do I receive direct shares or an SPV/fund interest?
- [ ] What share class sits underneath the structure?
- [ ] What is the latest primary financing valuation?
- [ ] What price is this specific transaction using?
- [ ] Is there a secondary-market premium?
- [ ] What fees and carried interest apply?
- [ ] Does the issuer have a right of first refusal?
- [ ] Is transfer approval required?
- [ ] How could I eventually sell?
- [ ] Is there a documented IPO, acquisition or secondary exit mechanism?
- [ ] Am I eligible in my jurisdiction?
- [ ] Have I read the binding investment documents?
If several of these answers are missing, a familiar company name is not enough to make the opportunity understandable.
What to Read Next
The Pre-IPO Investing Guide 2026 provides the broader framework for eligibility, ownership structures, valuation and exit risk.
Where an opportunity is offered through a pooled vehicle, Pre-IPO SPV vs Direct Share Ownership explains how legal ownership, fees and investor rights can differ.
For Anduril specifically, the Anduril Pre-IPO guide applies the same structure-first framework to a company with particularly strict private-share transfer controls.
Final Takeaway
A useful list of pre-IPO companies to invest in should not simply rank the most famous private companies.
In September 2026, four names worth researching are:
Stripe
Databricks
Anduril
Neuralink
But they represent very different private-market profiles.
Stripe combines mature financial infrastructure with periodic tender liquidity.
Databricks combines rapid enterprise AI growth with a very large private valuation.
Anduril combines defense-technology momentum with unusually important transfer and access restrictions.
Neuralink combines a large potential market with substantial clinical, regulatory and valuation uncertainty.
The company name should therefore be the beginning of the research process, not the end.
A better sequence is:
> Verify the company → verify the instrument → verify the price → verify the rights → verify the exit.
Official Resources
For due diligence, prioritize:
- company investor-relations or newsroom announcements;
- SEC filings and Investor.gov;
- current offering and subscription documents;
- issuer transfer restrictions;
- official platform product documentation.
Secondary-market estimates can be useful as reference points, but they should not replace binding transaction documents or verified primary-company information.
Full Disclaimer
This article is for informational and educational purposes only and does not constitute investment, financial, legal or tax advice, an offer to sell securities, or a solicitation to buy any investment.
References to Stripe, Databricks, Anduril and Neuralink are provided as research examples only. Their inclusion does not mean shares or investment products relating to these companies are currently available through MSX or any other platform.
Pre-IPO investments can involve loss of capital, illiquidity, uncertain valuations, limited disclosure, dilution, fees, carried interest, transfer restrictions, issuer approval requirements, rights of first refusal, long holding periods and regulatory restrictions.
Private-company financing valuations, tender prices, secondary-market indications and SPV prices may refer to different instruments and transactions and should not be treated as interchangeable or as continuously executable public-market prices.
Before participating in any private investment, review the applicable offering documents, legal structure, share class, eligibility requirements, fees, custody arrangements, transfer restrictions and exit provisions, and consider consulting qualified professional advisers.